Bluejay Diagnostics News

Bluejay Diagnostics | 8-K: Current report

Dec 4 17:32 ET

Bluejay Diagnostics | 8-K: Current report

Nov 18 06:33 ET

Bluejay Diagnostics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(5.1%),Anson Management GP LLC(5.1%), etc.

Nov 14 17:51 ET

Bluejay Diagnostics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)

Nov 14 15:57 ET

Bluejay Diagnostics | 10-Q: Q3 2024 Earnings Report

Nov 7 16:03 ET

Bluejay Diagnostics | 8-K: Current report

Oct 24 07:04 ET

Bluejay Diagnostics | 8-K: Current report

Oct 16 16:58 ET

Bluejay Diagnostics | DEFA14A: Others

Oct 16 16:58 ET

Bluejay Diagnostics | DEF 14A: Definitive information statements

Sep 10 18:09 ET

Bluejay Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Aug 30 17:53 ET

Bluejay Diagnostics | 8-K: Current report

Aug 28 17:28 ET

Bluejay Diagnostics | 8-K: Current report

Aug 21 14:20 ET

Bluejay Diagnostics | 10-Q: Q2 2024 Earnings Report

Aug 14 16:50 ET

Bluejay Diagnostics | DEF 14A: Definitive information statements

Jul 16 16:18 ET

Bluejay Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Jul 5 16:32 ET

Bluejay Diagnostics | SC 13G: Statement of acquisition of beneficial ownership by individuals-L1 Capital Global Opportunities Master Fund, Ltd.(9.99%)

Jul 3 16:08 ET

Bluejay Diagnostics | 8-K: Current report

Jun 28 16:53 ET

Bluejay Diagnostics | 424B1: Prospectus

Jun 28 12:38 ET

Bluejay Diagnostics | EFFECT: Others

Jun 27 06:03 ET

Bluejay Diagnostics | CORRESP: CORRESP

Jun 25 22:18 ET